Orexin-A and orexin-B (hypocretin-1 and hypocretin-2, respectively) are important hypothalamic neuro-peptides, which are encoded by a single mRNA transcript and stimulate food intake as well as regulate wakefulness. Here we determined the solution structure of orexin-A by NMR spectroscopy and by simulated-annealing calculation. The structural features of orexin-A involve two α-helices, with the hydrophobic residues disposed to on one side of helix, and hydrophilic residues to the other. A hydrophilic turn induced by two disulfide bonds provides the key difference between orexin-A and -B. With previous mutagenic studies, the derived structure of orexin-A provides us with a structure-functional view for novel drug design.
Introduction
The most abundant mammalian neuro-peptides characterized to date are involved in a multiplicity of the physiological functions, namely, thermoregulation, obesity, blood pressure, cardiovascular system (Murphy et al., 1983; De Wied et al., 1991; Smith et al., 1992; Li et al., 1996; Fan et al., 1997; de Lecea et al., 1998; Sakurai et al., 1998; Willie et al., 2001) . It has been reported that the peptides orexin-A and orexin-B (also called hcrt-1 and hcrt-2) are involved in a number of cell signal-transduction pathways, for example, feeding behavior and energy homeostasis (Sakurai et al., 1998; de Lecea et al., 1998) . Feeding behavior depends on a multiplex of metabolic, autonomic, endocrine, and environmental factors, which are coordinated by an appropriate state of cortical arousal (wakefulness). It has been reported that since orexin peptides have something to do with the sleep cycle, that a deficiency of orexin peptides generates narcoleptic symptoms (Willie et al., 2001) .
The mRNA of the precursor of these orexins was specifically found in the lateral hypothalamus and adjacent areas, which are extensively involved in the integrated processes that regulate feeding behavior and energy homeostasis (Bernardis et al., 1993; Bernardis et al., 1996) . However, a recent report demonstrated orexin-A expression in human peripheral tissues (Nakabayashi et al., 2003) . The orexin peptides are produced by the proteolytic cleavage of an oligo-peptide precursor, prepro-orexin, and both N-terminal pyroglutamyl cyclic forms, orexin-A and C, which are terminal amidation variants of these two peptides, are frequently found as post-translational modification products. Orexin-A, a 33-residue peptide, contains two disulfide bonds, whereas orexin-B, a 28-residue peptide, does not possess a cysteine residue, even though it has 46% sequence identity with orexin-A (Fig. 1) . Vertebrate orexin peptides show high sequence homology. Orexin peptides cloned from the amphibian Xenopus laevis were found to have high sequence homology with their mammalian counterparts (Willie et al., 2001) . In addition, both human and rat orexin receptors have been recognized as members of the seven-transmembrane protein family of orphan G-protein-coupled cell surface receptors (Sakurai et al., 1998) .
Orexin peptides stimulate food consumption and their production is regulated by nutritional state. NMR studies on several neuro-peptides have already provided convincing evidence concerning the importance of structure in the central regulation of obesity and energy balance (Darbon et al., 1992; Monks et al., 1996) . We previously reported that human orexin-B forms two α-helices connected by a small linker (Lee et al., 1999) . Here, we present the three-dimensional solution structure of human orexin-A as determined by twodimensional NMR spectroscopy and dynamical simulatedannealing calculation. In terms of comparing it with the human orexin-B structure, we describe the characteristics of the human orexin-A structure-function relationship. This study adds information on the structure-function relationships of orexin-A, and provides a structural background for further ligand-receptor recognition studies on orexin neuropeptides. was synthesized commercially (Anygen Co., Kwangju, Korea). The linear resin-bound peptide was synthesized as described above with Cys (Acm) in positions 6 and 12 and Cys (Trt) in positions 7 and 14. The synthetic peptide was purified by reverse-phase liquid chromatography using a Shim-Pack C18 column on a Water Delta Prep 4000 system. The disulfide bonded form of the peptide was characterized by the combined use of HPLC and MALDI-TOF mass spectrometry and confirmed by NMR spectroscopy: ββ NOE between disulfide-bonded cysteine residues shown in Fig. 1 (Werner et al., 1993) .
Materials and methods

Peptide synthesis and purification
Circular dichroism spectroscopy CD spectra of 80 µM human orexin-A were measured in 50 mM potassium phosphate buffer at various pHs, temperatures, and micelle conditions using a Jasco J-810 spectropolarimeter. CD spectra were recorded from 190 to 250 nm at a scanning rate of 50 nm/min with a time constant of 0.5 sec. Each CD spectrum was obtained by averaging 10 recordings with a step resolution of 0.2 nm and a bandwidth of 2.0 nm in cells with 0.1 mm path length (Koo et al., 2002) .
NMR spectroscopy NMR was performed upon 2 mM of the peptide in 50 mM potassium phosphate buffer at pH 7.0 in 100% D 2 O and 90% H 2 O/10% D 2 O. NMR spectra were recorded at 278 K on Bruker DRX-500 and DRX-600 spectrometers equipped with a triple-resonance probe and an x, y, z-shielded pulsed-field Fig. 1 . Alignment of the amino acid sequences of hypocretins/orexins and of the bombesin family residue in the carboxy-terminus. The topologies of the two disulfide bonds in human orexin-A are indicated on the sequence. Identical residues are boxed. The N-terminus of human orexin-A is a pyroglutamyl residue (< E). gradient coil. Two-dimensional (2D) NMR spectra were recorded in the phase-sensitive mode using time-proportional phase incrementation (Marion et al., 1983) for quadrature detection in the t 1 domain. 2D experiments were performed using doublequantum-filtered COSY (DQF-COSY) (Rance et al., 1983) , TOCSY (Davis et al., 1985) using a MLEV-17 spin-lock pulse sequence and a mixing time of 69.7 ms, and NOESY (Jeener et al., 1979) with mixing times of 200, 300, 400, 600 ms. For the DQF-COSY experiments, solvent suppression was performed by selective low-power irradiation of water resonance during the 2.0 s of relaxation delay. Solvent suppression for TOCSY and NOESY was achieved using a WATERGATE pulse sequence (Piotto et al., 1992) combined with a pulsed-field gradient pulse. All NMR spectra were acquired with 2048 complex data points in the t 2 and 256 increments in the t 1 dimension, with 32 scans per increment. Slowly exchanging amide protons were identified by lyophilizing fully protonated samples in H 2 O solutions, redissolving these in 100 % D 2 O, and immediately acquiring a series of one-dimensional NOESY and 2D-NOESY spectra.
3
J HNα coupling constants were determined from 2D-DQF-COSY spectra, and strip-transformed to 8 K × 1 K.
All NMR data were processed on a Silicon Graphics Indigo II workstation using nmrPipe/nmrDraw (Delaglio et al., 1995) or XWIN-NMR (Bruker Instruments, Karlsruhe, Germany) software and analyzed using the Sparky 3.60 program (Goddard et al., 2003) . Proton chemical shifts were expressed relative to the methyl resonance of internal sodium 2, 2-dimethyl-2-silapentane-5-sulfonic acid (DSS). dihedral angles, and 8 hydrogen-bond restraints were used. Crosspeak volumes were classified as strong, medium, or weak, corresponding to upper bound interproton distance restraints of 2.7, 3.3 and 5.0 Å, respectively (Cho et al., 2003) . Backbone dihedral restraints inferred from 3 J HNα coupling constants were used as −55 ± 5 o for a 3 J HNa of less than 6 Hz (Wagner et al., 1987; . Three-dimensional structures were calculated using hybrid distance geometry and the dynamic simulated annealing protocol, as previously described (Nilges et al., 1988a; Nilges et al., 1988b; Nilges et al. 1988c; , using the CNS 1.0 program on a SGI Indigo 2 workstation. The methodology employed was similar to the original protocol of Lee et al. (1994) . Final structures were analyzed using PROCHECK (Lakovski et al., 1993) and displayed using the Insight II (Accelrys Inc., San Diego, USA) and MOLMOL programs (Koradi et al., 1996) .
Structural restraints and structure calculations
Results and Discussion
Circular dichroism spectroscopy CD spectra of human orexin-A were acquired at various pHs, temperatures, and solvent conditions. CD spectra in aqueous solutions were measured at a peptide concentration of 80 µM in 50 mM potassium phosphate. Fig. 2A shows that orexin-A contains a helical conformation in a physiological environment (pH 7.0, 298 K) by ellipticity at 222 nm. pH and temperature differences were not significant factors of helicity. However, in membrane mimetic conditions (in DPC) the helicity of human orexin-A increased (Fig. 2B) 
NMR resonance assignments and secondary structures
Complete proton resonance assignments for human orexin-A were achieved using the standard sequential resonance assignment procedure. Once the individual spin systems had been classified, the backbone sequential resonance assignment was completed by d αN (i, i + 1) NOE connectivities in the 2D-NOESY spectrum. The chemical shifts of orexin-A are listed in Table 1 (Wishart et al., 1992) , and chemical shift index values (Kane et al., 2000) . of human orexin-A (PDB code: 1R02) was calculated using the experimental restraints derived from 2D-NOESY and DQF-COSY spectra collected at 278 K. A total of 50 distance geometry structures served as starting structures for dynamical simulated-annealing calculations for the peptide in H 2 O solutions. All 50 structures showed no restraint violations of greater than 0.5 Å for distances and 3 o for torsion angles. The 20 lowest energy structures (<SA> k ) of the 50 simulatedannealing structures were selected for detailed structural analysis. The average structure (< > k ) was calculated from the geometrical average of 20 <SA> k structure coordinates, and this was subjected to restraint energy minimization to correct covalent bonds and angle distortions. Table 2 summarizes the statistics of the final structures. The Ramachandran plot (not shown) for all 20 <SA> k structures showed that the φ, ψ angles of the final simulated-annealing structures were distributed properly in energetically acceptable regions. PROCHECK analysis then showed that all residues were in allowed regions of the Ramachandran map. The energies and structural statistics of the 20 <SA> k and the SA Table 2 . A best-fit superposition of the 20 <SA> k structures and the energy-minimized average structure (< > kr ) is shown in Fig. 4A , B. In Fig. 5A , the atomic rmsds of the final 20 structures for the individual residues are displayed with respected to the average structure (<SA>k).
The main structural features of human orexin-A are two ahelices spanning residues Cys and Cys 14 in its N-terminus (Fig. 5B ) and these bonds make a rigid turn conformation between the Arg 8 -Thr 11 residues. Human orexin-A and human orexin-B have similar structures, so orexin receptors bind both orexin peptides (Kane et al., 2000) . On comparing the two peptide structures, the residues of the Cys Gly 16 of human orexin-B, showing an rmsd of 0.8 Å for C a atoms. Both receptors, hOX1R (425 residues) and hOX2R (444 residues), belong to the class I subfamily within the superfamily of G-protein coupled receptors. They have identical conformations in the transmembrane, extra cellular loop, and the intra cellular loop 1, 2 regions. However, the Nterminal extra cellular domain, intracellular loop 3, and the Cterminal cytosolic domains have different conformations (Voisin et al., 2003) . Thus, the N-terminal extra cellular domain of hOX1R might distinguish human orexin-A and human orexin-B. From studies on canine narcolepsy, the Cterminal region of human orexin-A, a region identical with human orexin-B, is essential for hOX2R activation (Wieland et al., 2002) . However, in the case of human orexin-A, the binding affinity of human orexin-A without residues 1-14, showed 60-fold lower affinity for hOX1R, and 23-fold lower affinity for hOX2R. Human orexin-A without disulfide bonds showed similar results. These bonds were reported to play a key role in the stimulation of gastric acid secretion (Okumura et al., 2001 ). The rigid turn induced by the two disulfide bonds contains characteristic charged residues, RQKT. Although there is insufficient information about the interaction of this turn and receptors, it is apparent from a previous peptide mutation study (Voisin et al., 2003) that the N-terminal extra cellular domain of hOX1R might interact with the turn of human orexin-A and enhance the receptor binding affinity of human orexin-A. Moreover, breakage of these disulfide bonds might disrupt the turn conformation and induce lower binding human orexin-A affinity. In addition, a study of the E54K mutation in hOX2R (Hungs et al., 2001) suggested that the N-terminal extra cellular domain of hOX receptors might also interact with the C-terminal of orexin peptides. In conclusion, whereas the C-terminal helix region of orexin peptides might be essential for interaction with hOX receptors, the N-terminal region Glu ) are located on the other side. There is accumulating evidence that many hormones display amphiphilic secondary structures, mainly α-helices. These kinds of amphiphilic peptides have the ability to selfaggregate or dimerize (Mirjam et al., 2002) , but the data from the analytical ultra centrifuge analysis showed that the monomer form predominated under the NMR experimental condition.
Human neuropeptide Y, are orexin-like signaling peptide, is negatively regulated by leptin (Zarjevski et al., 1993; Stephens et al., 1995) , and has been characterized as one of the positive regulators of feeding behavior. Monks et al. (1996) suggested that the monomeric human neuropeptide Y molecule could be associated with the hydrophobic side in the α-helical region at high concentration, and that it might even form a dimer (Mirjam et al., 2002) . But in our study, the monomeric form dominated and the structure of monomeric form was elucidated. It is interesting to note that the solution structure of human neuropeptide Y also contains a kink in the middle of amphiphilic helix (Monks et al., 1996) . Schwartz et al. (1998) proposed that the orexins play a role analogous to that of neuropeptide Y in the control of energy balance. Even though orexins and neuropeptide Y share low sequence homology, we can presume that their similar biological functions stem from the structural homology between the two neuropeptides. Interestingly, the human orexin-A cappinghelix conformation induced by disulfide bonds extends duration of action versus neuropeptide Y (Willie et al., 2001) .
In this study, we demonstrate the solution structure of human orexin-A and compared this with human orexin-B. Like other neuropeptides, its conformation shows an amphiphilic helix with a unique RQKT turn. In our future work, the interaction between orexin peptides and receptors will be further studied. We hope to obtain more detailed information on orexin-receptor interaction for novel drug development. 
